Histone Deacetylase (HDAC) 1 Controls the Expression of Beta Defensin 1 in Human Lung Epithelial Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kallsen, Kimberley ^a   Andresen, Ellen ^a   Heine, Holger ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE H3; MESSENGER RNA; TRICHOSTATIN A;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEFB1 GENE; ENZYME INHIBITION; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACETYLATION; ASTHMA; BETA-DEFENSINS; CELL LINE; CHROMATIN; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; LUNG; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84869761100     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050000     Document Type: Article

References (44)

1. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
2. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
3. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW, (1993) Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 155: 408-413.
4. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG, (1995) hBD-1: a novel beta-defensin from human plasma. FEBS Lett 368: 331-335.
5. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, et al. (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553-560.
6. Zhao C, Wang I, Lehrer RI, (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396: 319-322.
7. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, et al. (1998) Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101: 1633-1642.
8. Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, et al. (2002) Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun 291: 17-22.
9. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA, (2003) Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 41: 90-96.
10. Levy H, Raby BA, Lake S, Tantisira KG, Kwiatkowski D, et al. (2005) Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol 115: 252-258.
11. Prado-Montes de Oca E, Garcia-Vargas A, Lozano-Inocencio R, Gallegos-Arreola MP, Sandoval-Ramirez L, et al. (2007) Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. International Archives of Allergy and Immunology 142: 211-218.
12. Schaefer AS, Richter GM, Nothnagel M, Laine ML, Ruhling A, et al. (2010) A 3′ UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun 11: 45-54.
13. Andresen E, Gunther G, Bullwinkel J, Lange C, Heine H, (2011) Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One 6: e21898.
14. Sherman H, Chapnik N, Froy O, (2006) Albumin and amino acids upregulate the expression of human beta-defensin 1. Mol Immunol 43: 1617-1623.
15. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH, (2002) Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106: 517-525.
16. Schaefer TM, Fahey JV, Wright JA, Wira CR, (2005) Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 174: 992-1002.
17. Zhu BD, Feng Y, Huang N, Wu Q, Wang BY, (2003) Mycobacterium bovis bacille Calmette-Guerin (BCG) enhances human beta-defensin-1 gene transcription in human pulmonary gland epithelial cells. Acta Pharmacol Sin 24: 907-912.
18. Lehmann J, Retz M, Harder J, Krams M, Kellner U, et al. (2002) Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis 2: 20.
19. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G, (2006) Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 306: 153-182.
20. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, et al. (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976.
21. Allfrey VG, Faulkner R, Mirsky AE, (1964) Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51: 786-794.
22. Avalos JL, Bever KM, Wolberger C, (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17: 855-868.
23. Bhalla KN, (2005) Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 23: 3971-3993.
24. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, et al. (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734-36741.
25. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, et al. (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409: 581-589.
26. Kwon HJ, Owa T, Hassig CA, Shimada J, Schreiber SL, (1998) Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc Natl Acad Sci USA 95: 3356-3361.
27. Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, et al. (2003) Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther 307: 720-728.
28. Balasubramanian S, Ramos J, Luo W, Sirisawad M, Verner E, et al. (2008) A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia 22: 1026-1034.
29. Adcock IM, Ford P, Ito K, Barnes PJ, (2006) Epigenetics and airways disease. Respir Res 7: 21.
30. Rosato RR, Grant S, (2003) Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther 2: 30-37.
31. Halili MA, Andrews MR, Sweet MJ, Fairlie DP, (2009) Histone deacetylase inhibitors in inflammatory disease. Curr Top Med Chem 9: 309-319.
32. Barnes PJ, Adcock IM, Ito K, (2005) Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25: 552-563.
33. Adcock IM, Ito K, Barnes PJ, (2005) Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2: 445-455.
34. Yoshida M, Horinouchi S, Beppu T, (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17: 423-430.
35. Yoshida M, Furumai R, Nishiyama M, Komatsu Y, Nishino N, et al. (2001) Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol 48Suppl 1: S20-S26.
36. Halili MA, Andrews MR, Labzin LI, Schroder K, Matthias G, et al. (2010) Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. JLeukocBiol 87: 1103-1114.
37. Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, et al. (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 45: 495-528.
38. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
39. Adenuga D, Yao H, March TH, Seagrave J, Rahman I, (2009) Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 40: 464-473.
40. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, et al. (2010) Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A 107: 8772-8777.
41. Vogelmeier C, Buhl R, Criee CP, Gillissen A, Kardos P, et al. (2007) [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin]. Pneumologie 61: e1-40.
42. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG, (2006) Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 7: 53.
43. Prado-Montes de Oca E, (2010) Human beta-defensin 1: a restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol 42: 800-804.
44. Bullwinkel J, Baron-Luhr B, Ludemann A, Wohlenberg C, Gerdes J, et al. (2006) Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 206: 624-635.